---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001258"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2026-07-30T16:02:58+00:00"
generated_at: "2026-07-30T16:04:06.860837+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience announces 1-for-15 reverse stock split effective Aug 3, 2026 to regain Nasdaq compliance

## Summary
- Reverse split ratio 1-for-15; effective 12:01 a.m. ET on August 3, 2026.
- Outstanding shares reduced from ~24.8M to ~1.65M; authorized shares cut from 220M to 14.7M.
- Primary goal: regain Nasdaq minimum $1.00 bid price compliance under Listing Rule 5550(a)(2).
- No fractional shares issued; fractional shares rounded up to whole shares.
- Stock symbol LEXX unchanged; new CUSIP 52886N604.

## SEC filing metadata
- accession: 0001640334-26-001258
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2026-07-30T16:02:58+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/0001640334-26-001258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001258
- JSON: https://secwatch.observer/filing/0001640334-26-001258.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001258.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.